Skip to main content
. 2022 Oct 11;22:247. doi: 10.1186/s12866-022-02662-3

Table 2.

Different antibiotic resistance phenotypes and indices in 17 MDR P. mirabilis isolates

Antibiotic profile No. of AB groups No of phenotypes (%) No. of AB showing resistance MARI
PRL/AMC/ATM/FOX/CTX/CAZ/CIP/TS/AK 4 1 (5.9%) 9 0.82
PRL/AMC/ATM/CTX/CAZ/CIP/TS/GM/AK 4 2 (11.8%) 9 0.82
PRL/AMC/FOX/CTX/CAZ/CIP/TS/GM/AK 4 1 (5.9%) 9 0.82
PRL/AMC/FOX/CIP/TS/GM 4 1 (5.9%) 6 0.55
PRL/FOX/CTX/CAZ/CIP/TS/GM/AK 4 1 (5.9%) 8 0.73
PRL/CTX/CAZ/CIP/TS/GM/AK 4 2 (11.8%) 7 0.64
PRL/CTX/CAZ/CIP/GM/AK 4 1 (5.9%) 6 0.55
AMC/FOX/TS/AK 4 1 (5.9%) 4 0.36
ATM/FOX/CTX/CAZ/CIP/TS/GM/AK 4 3 (17.6%) 8 0.73
AMC/FOX/CTX/TS/GM 3 1 (5.9%) 5 0.45
AMC/TS/GM 3 2 (11.8%) 3 0.27
PRL/ TS/GM 3 1 (5.9%) 3 0.27

PRL Piperacillin (100 μg), AMC Amoxicillin/clavulanic acid (30 μg), ATM Aztreonam (30 μg), IPM Imipenam (10 μg), FOX Cefoxitin (30 μg), CTX Cefotaxime, CAZ Ceftazidime (30 μg), CIP Ciprofloxacin (5 μg), TS Cotrimoxazole (25 μg), GM Gentamicin (10 μg) and AK Amikacin (30 μg), AB Antibiotic, MARI Multiple antibiotic resistance index